SEC Filing Summary: Park Ha Biological Technology Co., Ltd.
Business Context and Reporting Period
This Form 6-K filing by Park Ha Biological Technology Co., Ltd., a Cayman Islands company, covers the month of September 2025. The report is submitted in connection with the Company's 2025 Annual General Meeting. The Company's principal executive office is located in Wuxi, Jiangsu Province, People's Republic of China.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a notice of corporate governance proceedings rather than a financial results report.
Material Changes
No material changes to financial performance or operations are disclosed in this filing. The document focuses solely on the administrative logistics of the upcoming Annual General Meeting.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It includes the following exhibits:
- Exhibit 99.1: Notice of 2025 Annual General Meeting, dated September 12, 2025.
- Exhibit 99.2: Form of Proxy Card for shareholders.
Key Facts for Investors to Verify
- Verify the date, time, and location of the 2025 Annual General Meeting as detailed in the attached Notice.
- Confirm the specific agenda items and proposals to be voted upon at the meeting.
- Review the Company's most recent Form 20-F or quarterly reports for actual financial performance data, as this filing does not contain such metrics.